GSK and Operose Health Shingles Vaccination Project Report

This document is a report summarizing the outcomes of a collaborative project between GSK and Operose Health aimed at improving the uptake of the Shingles National Immunisation Programme (NIP) among underserved populations. The project was conducted from November 2023 to December 2024 across 34 GP practices in London, targeting a registered patient population of 352,841. The primary objective was to increase the vaccination uptake by 10% from a baseline of 40%. The report details various project objectives, including identifying barriers to vaccination, creating a Quality Improvement (QI) template, and educating healthcare professionals about the importance of shingles vaccination. The study employed qualitative and quantitative methods, including focus groups and patient surveys, to gather data on patient demographics and vaccination knowledge. Results indicated that significant barriers existed, including poor communication and awareness among patients. The report also outlines the development of a QI toolkit designed to enhance vaccination delivery and accessibility in primary care settings, aiming to address health inequalities.